CU6
Click for more information
3.21% $8.45 clarity pharmaceuticals ltd

Ann: Theranostic prostate cancer trial advances to multi-dose, page-29

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. SU27
    607 Posts.
    lightbulb Created with Sketch. 61
    clock Created with Sketch.
    17/03/24
    18:50
    Post #: 72929732
    ▪ RP2D is the dose that does not exceed the DLT limit established by the. dose escalation plan. ▪ Often it is exceeded during the course of a phase 1 study. ▪ The dose escalation scheme is guided by the DLTs that occur during. the observation period, but the safety and tolerability determinations.

    Hope this helps…
    CU6 Price at posting: $2.65 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

CC9 Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
right-arrow Created with Sketch.
NEWS Significant increase in revenue from faster NDIS approvals and launch of new leasing programs
right-arrow Created with Sketch.
NEWS New multi-lode gold shoot discovery boosts development potential—find out who's behind this
right-arrow Created with Sketch.
NEWS Gold mineralisation discovered along major shear zone at Challa Gold Project, confirming two new intersections in latest aircore drilling
right-arrow Created with Sketch.
AHK New MRE update reveals significant resource uplift at Sandy Mitchell—discover the details
right-arrow Created with Sketch.
NEWS Significant shallow gold intersections at Tambourah King reveal potential extensions to the lode gold system, with promising RC drill results and more assays pending
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
(20min delay)
Last
$8.45 		Change
-0.280(3.21%) 		Mkt cap ! $2.742B
Open High Low Value Volume
$8.62 $8.68 $8.42 $2.424M 284.8K

Buyers (Bids)

No. Vol. Price($)
3 22 $8.45
 

Sellers (Offers)

Price($) Vol. No.
$8.46 24 2
View Market Depth
Last trade - 11.40am 04/10/2024 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.